about
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations.Intrauterine growth restriction caused by underlying congenital cytomegalovirus infectionMelanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature.Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.Characteristics and Clinical Implications of Reactive Germinal Centers in the Bone Marrow.Epstein-Barr virus-positive plasmacytoma in immunocompetent patients.Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome.CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.A rare histologic variant of a common lymphoma.Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1.Disseminated blastic plasmacytoid dendritic cell neoplasm.Unusual breast mass: lymphoma with crystal-storing histiocytosis.Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?Dopamine receptor mechanism(s) and antinociception and tolerance induced by swim stress in formalin testMultimodality evaluation of a rare intracardiac tumor: cardiac hemangiomaPolyomavirus infection and urothelial carcinomaBreast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow InvolvementSystematic Use of Fluorescence in situ Hybridization (FISH) and Clinicopathological Features in the Screening of PDGFRB Rearrangements of Patients with Myeloid/Lymphoid NeoplasmsPatient with mixed-phenotype acute leukemia with CBFB rearrangementValidation of the 2017 revision of the WHO chronic myelomonocytic leukemia categoriesClinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiableImmunopathology of Kikuchi-Fujimoto Disease: A reappraisal using novel immunohistochemistry combinationsEarly T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapyA proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphomaMolecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AMLRoutine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatmentsAssociation of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients
P50
Q33425087-F5C7FF95-C7A8-47E6-9C2E-5924FE9FE40DQ34340438-3903DF31-647A-485C-8D5A-5A5BC8EB3515Q37719762-37897299-2C9B-4D0C-9E0A-A68D64291F53Q38205341-81B1C71A-193C-450C-9474-67F58BB1C8B6Q39025300-D65DF615-DAE8-4B49-9350-98ED77D9DD59Q40243326-B25847ED-BD99-4863-82D7-4D87AD91D8D9Q41565100-54B7B824-0A59-4BBB-900D-FD14D052EE89Q43242156-B8090040-40F4-401D-AE8E-9FE77680D1C6Q46543020-43F4C6D4-1949-4636-A35B-AA50538C9447Q48103458-17277FA0-A9D4-4BFC-840F-CECD52798EDEQ48123141-D91B8742-8637-4F3F-A770-278BDF8211DBQ48184250-3FD63FAD-55A1-4A39-9AE9-44BDF06576ADQ53213010-73483620-EC55-46F5-A3A2-3218D16F67A8Q53481081-BF771595-818F-4C1E-A221-DFBE310171D1Q53614224-5EBA4728-625A-4F21-9A3D-A48857B4CE59Q60907709-0BE20DC8-B813-4455-9656-5695E4EDE70BQ80130069-BC3A9B29-C2A5-44E5-9433-3F68F1B0F4D5Q84592179-9CA29C89-DD43-4894-AE86-4C9C0CF8F668Q85125676-88B182E5-0401-487A-AAC7-1D23D0B8ED82Q88319298-EAE7BFC8-C71E-4357-978D-73B528A8452EQ89828844-318F87B2-3D5A-4EB6-A8EC-412807834C44Q90223575-795D3497-E84A-43FA-B2C0-27328713B5EDQ90579239-F88E8858-6A5E-4648-A7AC-1CC41CBBCEA9Q90835894-CB3666FA-D48F-4FA7-B4FE-75CA2A48A78BQ91638072-2A1D6B08-0E58-48CA-9487-857B7ED5165EQ92106917-66CCDF82-2C4C-462F-A242-AFA732979CBBQ92210685-1C7A27C7-6425-4B9B-9E01-6D4D5C13C919Q92432391-2F8C7A2D-48AE-4244-B2C9-90D65FF84D1DQ92611583-7F3D0761-93AB-4C99-8288-9D2AFF71EFBCQ92692686-3B8B2A94-F8E8-4B3A-9795-F322BDB1A659Q93055959-8A731D4B-8455-4D3A-8512-D4F0D0B687F8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sanam Loghavi
@ast
Sanam Loghavi
@en
Sanam Loghavi
@es
Sanam Loghavi
@nl
Sanam Loghavi
@sl
type
label
Sanam Loghavi
@ast
Sanam Loghavi
@en
Sanam Loghavi
@es
Sanam Loghavi
@nl
Sanam Loghavi
@sl
prefLabel
Sanam Loghavi
@ast
Sanam Loghavi
@en
Sanam Loghavi
@es
Sanam Loghavi
@nl
Sanam Loghavi
@sl
P106
P1153
14071732700
P31
P496
0000-0001-8980-3202